Navigation Links
Antibiotics Found To Increase The Risk Of Developing Breast Cancer

Women who took the most antibiotics , or who took the drugs for at least 501 days -- faced double the risk of // developing breast cancer over an average of about 17 years, compared with women who didn't use the drugs, the study showed.

Also, since antibiotics are widely used to treat a variety of common infections caused by bacteria, some pneumonias and many gastrointestinal infections, it may be that women who never took the drugs were unusually healthy and therefore unusually resistant to cancer, the researchers said.

The study involved 2,266 women 20 and older who developed invasive breast cancer and who were compared with 7,953 women who did not get breast cancer. An increased breast cancer risk was found with increasing use of antibiotics, with the greatest increased risk in women who took the drugs for at least 501 days. Even women who had up to 25 prescriptions over about 17 years faced an increased risk -- about 1.5 times higher than nonusers. An increased breast cancer risk was found for all types of antibiotics, including penicillins.

Researchers suggest a few theories that might explain how antibiotics would lead to breast cancer, the medications' effects on intestinal bacteria could change the body's immune system or how the body metabolizes foods that protect against cancer, they said.

Specialists says the theorized link is potentially worrisome, since antibiotics are so commonly used -- sometimes unnecessarily for conditions in which they are ineffective, including colds and other viruses. But researchers say more research needed because it could have been the diseases women used antibiotics to treat -- rather than the drugs themselves -- that increased breast cancer risk.
'"/>




Page: 1

Related medicine news :

1. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
2. Antibiotics Helps Autism
3. Antibiotics losing their power against acne
4. Antibiotics help heart patients
5. Antibiotics May Help Prevent Strokes
6. Antibiotics Overload For Kids Questioned
7. The Use Of Antibiotics Questioned
8. The Dangers Of Prescribing Antibiotics
9. Eliminating Eye Infection With Antibiotics
10. Eliminating Eye Infection With Antibiotics
11. Understanding The Effectiveness Of Antibiotics In Treating Urinary Tract Infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... ... April 28, 2016 , ... Sanford Health’s work in cellular ... of researchers and leaders from Sanford Health were selected to participate in the ... Impact ” and receive the 2016 Pontifical Key Innovation Award at the Vatican. ...
(Date:4/28/2016)... ... 2016 , ... CastCoverz!, America’s #1 trusted brand for cast ... waterproof cast protector . As the largest one-stop, orthopedic shop, CastCoverz! offers ... night, weatherproof and waterproof covers for most orthopedic devices, including but not limited ...
(Date:4/28/2016)... (PRWEB) , ... April 28, ... ... Standards Consortium (CDISC) announces today the open availability of a new CDISC ... and catalogs for registering clinical trials. This innovative standard will make it ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... and the Campaign for Tobacco-Free Kids, a leading force in the fight to ... federal, state and local policies that can help reduce tobacco use. The initiative ...
(Date:4/28/2016)... ... 28, 2016 , ... In 2011, TIME magazine named Herr the “Leader of ... technology that marries human physiology with electromechanics. He continues that work as Director of ... of BionX , a leader in the field of prosthetic devices. , After ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  ValGenesis, Inc., ... Management Solutions (VLMS) today announced that a ... for sufferers of chronic kidney failure has ... manage their corporate validation process. The global ... software solution to manage their validation processes ...
(Date:4/27/2016)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... second quarter ended March 26, 2016.  GAAP diluted ... and non-GAAP diluted EPS of $0.47 increased 14.6%.  ... reported basis, and 6.3% on a constant currency ... quarter, highlighted by 14.6% growth in non-GAAP EPS," ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: